[Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
Pulmonary complications in patients with ulcerative colitis treated with 5-aminosalicylic acid are infrequent adverse events. The authors present a 35-year-old man, taking sulfasalazine and mesalazine in whom pulmonary abnormalities resembling tuberculosis were observed during several months of therapy. Withdrawal of mesalazine resulted in complete resolution of lung injury. Patient is doing well on maintenance treatment with immunosuppressants
Radwan
Piotr
P
Katedra i Klinika Gastroenterologii AM, Lublinie 1.
łupina
Tomasz
T
Radwan-Kwiatek
Karolina
K
Milanowski
Janusz
J
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000517:prevention & control; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects*; D011859:Radiography; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D012460:Sulfasalazine; D019804:Mesalamine